Stay updated on CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial

Sign up to get notified when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page revision/version label from v3.5.2 to v3.5.3, indicating a minor site build or UI release rather than a change to the underlying clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:39:18.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:07.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the Record History page.
    Difference
    0.1%
    Check dated 2026-03-19T06:35:23.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The record history now shows a new site revision (v3.4.3) added, replacing the previous revision (v3.4.2).
    Difference
    0.1%
    Check dated 2026-03-12T03:26:31.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    New Study Status and Recruitment Status entries were added, including a Terminated status on 2026-03-03, a 2026-02-27 update (version 16), and a <75% participation indicator. The previous 'Active, not recruiting' status entry was removed (as of 2025-11-21).
    Difference
    0.6%
    Check dated 2026-03-05T00:59:23.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    New revision entry Revision: v3.4.2 was added to the history and older notices including Revision: v3.4.1 and a site-wide government funding status notice were removed; these are administrative UI changes and do not affect the study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T12:18:10.000Z thumbnail image

Stay in the know with updates to CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.